Takeda starts World’s first norovirus vaccine field trial
21 June 2016 | By Victoria White, Digital Content Producer
Takeda has dosed the first subject in a Phase IIb field efficacy trial of its norovirus vaccine candidate, TAK-214...
List view / Grid view
News
Phase II study of relebactam in UTIs meets primary endpoint
21 June 2016 | By Victoria White, Digital Content Producer
The addition of relebactam is designed to restore activity of imipenem against certain imipenem-resistant strains of Gram-negative bacteria...
Study finds mobile phones used by hospital staff harbour viruses
21 June 2016 | By Victoria White, Digital Content Producer
A study from University Hospital of Saint-Étienne in France reveals that mobile devices are often also contaminated by viral RNA...
Denosumab may prevent breast cancer in women with BRCA1 gene mutation
20 June 2016 | By Victoria White, Digital Content Producer
Researchers have discovered that an existing medication, denosumab, may prevent breast cancer in women carrying a faulty BRCA1 gene...
An innovative approach to collecting Real World Data
20 June 2016 | By Victoria White, Digital Content Producer
A new approach that uses social media could help OTC brands collect data in a pertinent, low cost manner to support their licensed indications...
UCL Technology Fund invests £1m in gene therapy company, Freeline
20 June 2016 | By Victoria White, Digital Content Producer
Freeline is developing and commercialising gene therapies for bleeding and other life threatening or debilitating disorders...
Enstilar launches in the UK for patients with plaque psoriasis
Enstilar is the first fixed-combination, cutaneous foam spray for the once-daily topical treatment of all extents of plaque psoriasis...
Approval for first-in-human Zika vaccine trial to go ahead
20 June 2016 | By Victoria White, Digital Content Producer
Inovio and GeneOne Life Science have received approval to initiate a Phase I human trial to evaluate Inovio’s Zika DNA vaccine (GLS-5700)...
Verona secures funding commitments to help progress RPL554
20 June 2016 | By Victoria White, Digital Content Producer
Verona Pharma has successfully secured funding commitments to raise gross proceeds of £44.7m through a conditional placing with new and existing investors...
Expanded Phase II trial of savolitinib in NSCLC starts
20 June 2016 | By Victoria White, Digital Content Producer
A Phase II expansion of the ongoing TATTON trial has been initiated to evaluate savolitinib (AZD6094) in epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC) patients.
Esteban Santos appointed Amgen’s vice president, Operations
20 June 2016 | By Victoria White, Digital Content Producer
Santos will be responsible for Amgen's Operations organisation, including manufacturing, process development, quality, engineering and global supply chain...
Iron deficiency anaemia treatment Feraccru launches in the UK
17 June 2016 | By Victoria White, Digital Content Producer
Feraccru (ferric maltol) is now available in the UK as a treatment for adults with iron deficiency anaemia in patients with inflammatory bowel disease...
Takeda and M2Gen team up with ORIEN to speed drug development
17 June 2016 | By Victoria White, Digital Content Producer
Takeda and M2Gen are to collaborate with ORIEN to speed the development of cancer therapeutics through health informatics...
Pfizer breaks ground on new biologics manufacturing facility
17 June 2016 | By Victoria White, Digital Content Producer
Pfizer will invest more than $200 million in the development of the state-of-the-art facility that will enable the production of high-quality, complex biologics...
Keytruda superior to chemotherapy in NSCLC study
17 June 2016 | By Victoria White, Digital Content Producer
The KEYNOTE-024 trial investigating Keytruda in patients with previously untreated advanced non-small cell lung cancer has met its primary endpoint...
